| Year |
Citation |
Score |
| 2022 |
Morrison SL, Shin SU. Genetically engineered antibodies and their application to brain delivery. Advanced Drug Delivery Reviews. 15: 147-175. PMID 35524387 |
0.39 |
|
| 2022 |
Zettlitz KA, Salazar FB, Yamada RE, Trinh KR, Vasuthasawat A, Timmerman JM, Morrison SL, Wu AM. 89Zr-ImmunoPET shows therapeutic efficacy of anti-CD20 interferon-α fusion protein in a murine B-cell lymphoma model. Molecular Cancer Therapeutics. PMID 35086952 DOI: 10.1158/1535-7163.MCT-21-0732 |
0.363 |
|
| 2019 |
Pioli PD, Casero D, Montecino-Rodriguez E, Morrison SL, Dorshkind K. Plasma Cells Are Obligate Effectors of Enhanced Myelopoiesis in Aging Bone Marrow. Immunity. PMID 31303400 DOI: 10.1016/J.Immuni.2019.06.006 |
0.341 |
|
| 2019 |
Xu S, Zhou T, Doh HM, Trinh KR, Catapang A, Lee JT, Braas D, Bayley NA, Yamada RE, Vasuthasawat A, Sasine JP, Timmerman JM, Larson SM, Kim Y, Macleod AR, ... Morrison SL, et al. An HK2 antisense oligonucleotide induces synthetic lethality in HK1-HK2+ multiple myeloma. Cancer Research. PMID 30885978 DOI: 10.1158/0008-5472.Can-18-2799 |
0.321 |
|
| 2019 |
Vasuthasawat A, Yamada RE, Trinh KR, Rokni N, Morrison SL, Timmerman JM. In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells Blood. 134: 1575-1575. DOI: 10.1182/Blood-2019-131890 |
0.464 |
|
| 2018 |
Young PA, Yamada RE, Trinh KR, Vasuthasawat A, De Oliveira S, Yamada DH, Morrison SL, Timmerman JM. Activity of Anti-CD19 Chimeric Antigen Receptor T Cells Against B Cell Lymphoma Is Enhanced by Antibody-Targeted Interferon-Alpha. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 38: 239-254. PMID 29920129 DOI: 10.1089/Jir.2018.0030 |
0.394 |
|
| 2017 |
Li Z, Zhu Y, Li C, Trinh R, Ren X, Sun F, Wang Y, Shang P, Wang T, Wang M, Morrison SL, Zhang J. Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer. Oncoimmunology. 6: e1290038. PMID 28405526 DOI: 10.1080/2162402X.2017.1290038 |
0.398 |
|
| 2016 |
Vasuthasawat A, Yoo EM, Trinh KR, Lichtenstein A, Timmerman JM, Morrison SL. Targeted immunotherapy using anti-CD138-interferon α fusion proteins and bortezomib results in synergistic protection against multiple myeloma. Mabs. 0. PMID 27362935 DOI: 10.1080/19420862.2016.1207030 |
0.757 |
|
| 2016 |
Kendle RF, Kimaiyo DK, Yamada RE, Young P, Vasuthasawat A, Trinh RK, Morrison SL, Timmerman J. Ibrutinib plus anti-CD20-interferon alpha fusion protein for treatment of B cell lymphomas. Journal of Clinical Oncology. 34: e14567-e14567. DOI: 10.1200/Jco.2016.34.15_Suppl.E14567 |
0.386 |
|
| 2015 |
Vega GG, Franco-Cea LA, Huerta-Yepez S, Mayani H, Morrison SL, Bonavida B, Vega MI. Overcoming rituximab drug-resistance by the genetically engineered anti-CD20-hIFN-α fusion protein: Direct cytotoxicity and synergy with chemotherapy. International Journal of Oncology. 47: 1735-48. PMID 26398317 DOI: 10.3892/Ijo.2015.3170 |
0.336 |
|
| 2015 |
Yamada DH, Elsaesser H, Lux A, Timmerman JM, Morrison SL, de la Torre JC, Nimmerjahn F, Brooks DG. Suppression of Fcγ-receptor-mediated antibody effector function during persistent viral infection. Immunity. 42: 379-90. PMID 25680277 DOI: 10.1016/J.Immuni.2015.01.005 |
0.448 |
|
| 2015 |
Valenzuela NM, Trinh KR, Mulder A, Morrison SL, Reed EF. Monocyte recruitment by HLA IgG-activated endothelium: the relationship between IgG subclass and FcγRIIa polymorphisms. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 15: 1502-18. PMID 25648976 DOI: 10.1111/Ajt.13174 |
0.471 |
|
| 2015 |
Yoo EM, Trinh KR, Tran D, Vasuthasawat A, Zhang J, Hoang B, Lichtenstein A, Morrison SL. Anti-CD138-targeted interferon is a potent therapeutic against multiple myeloma. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 35: 281-91. PMID 25353626 DOI: 10.1089/Jir.2014.0125 |
0.766 |
|
| 2015 |
Timmerman JM, Steward KK, Yamada RE, Young PA, Minning DM, Sachdev RK, Gresser MJ, Khare SD, Morrison SL. Antibody-Interferon-Alpha Fusion Protein Therapy for the Treatment of B-Cell Non-Hodgkin Lymphoma: Enhanced ADCC, Inhibition of Proliferation, and In Vivo Eradication of CD20+ Human Lymphomas Blood. 126: 2762-2762. DOI: 10.1182/Blood.V126.23.2762.2762 |
0.491 |
|
| 2015 |
Valenzuela NM, Thomas KA, Zartarian M, Song J, Trinh KR, Morrison SL, Reed EF. OR5 Igg subclass and concentration are determinants of HLA class I antibody capacity to fix complement in in vitro clinical and functional assays Human Immunology. 76: 5. DOI: 10.1016/J.Humimm.2015.07.011 |
0.398 |
|
| 2015 |
Payés CJ, Daniels‐Wells TR, Maffía PC, Penichet ML, Morrison SL, Helguera G. Genetic Engineering of Antibody Molecules Reviews in Cell Biology and Molecular Medicine. 1: 1-52. DOI: 10.1002/3527600906.Mcb.200200007.Pub2 |
0.514 |
|
| 2014 |
Young PA, Morrison SL, Timmerman JM. Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety. Seminars in Oncology. 41: 623-36. PMID 25440607 DOI: 10.1053/J.Seminoncol.2014.08.002 |
0.44 |
|
| 2014 |
Morrison SL, Yoo EM. Genetically Engineered Antibody Molecules Reference Module in Biomedical Research. DOI: 10.1016/B978-0-12-801238-3.00129-X |
0.737 |
|
| 2013 |
Trinh KR, Vasuthasawat A, Steward KK, Yamada RE, Timmerman JM, Morrison SL. Anti-CD20-interferon-β fusion protein therapy of murine B-cell lymphomas. Journal of Immunotherapy (Hagerstown, Md. : 1997). 36: 305-18. PMID 23719241 DOI: 10.1097/Cji.0B013E3182993Eb9 |
0.387 |
|
| 2013 |
Asai T, Morrison SL. The SRC family tyrosine kinase HCK and the ETS family transcription factors SPIB and EHF regulate transcytosis across a human follicle-associated epithelium model. The Journal of Biological Chemistry. 288: 10395-405. PMID 23439650 DOI: 10.1074/Jbc.M112.437475 |
0.335 |
|
| 2013 |
De Oliveira SN, Wang J, Ryan C, Morrison SL, Kohn DB, Hollis RP. A CD19/Fc fusion protein for detection of anti-CD19 chimeric antigen receptors. Journal of Translational Medicine. 11: 23. PMID 23360526 DOI: 10.1186/1479-5876-11-23 |
0.44 |
|
| 2013 |
Yamada RE, Steward KK, Ngarmchamnanrith G, Trinh RK, Khare S, Sachdev R, Grewal IS, Morrison SL, Timmerman J. Anti-CD20-interferon-alpha fusion protein has superior in vivo activity against human B-cell lymphomas compared to rituximab and enhanced complement-dependent cytotoxicity in vitro. Journal of Clinical Oncology. 31: 3024-3024. DOI: 10.1200/Jco.2013.31.15_Suppl.3024 |
0.413 |
|
| 2013 |
Yamada R, Steward K, Ngarmchamnanrith G, Trinh R, Khare S, Sachdev R, Grewal I, Morrison S, Timmerman J. Antibody-CD20-interferon-alpha fusion protein has superior in vivo activity against human B cell lymphomas compared to Rituximab, and enhanced complement-dependent cytotoxicity in vitro Journal For Immunotherapy of Cancer. 1: P263. DOI: 10.1186/2051-1426-1-S1-P263 |
0.311 |
|
| 2012 |
Yoo E, Vasuthasawat A, Tran D, Lichtenstein A, Morrison S. Anti-CD138-IFNα Fusion Proteins Are Effective in Treating Multiple Myeloma Blood. 120: 939-939. DOI: 10.1182/Blood.V120.21.939.939 |
0.755 |
|
| 2011 |
Ngarmchamnanrith G, Yamada RE, Steward KK, Khare S, Sachdev R, Morrison SL, Timmerman J. Activity of anti-CD20-interferon-α fusion protein against human B-cell lymphomas. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 8047. PMID 28023567 DOI: 10.1200/Jco.2011.29.15_Suppl.8047 |
0.414 |
|
| 2011 |
Mershon-Shier KL, Vasuthasawat A, Takahashi K, Morrison SL, Beenhouwer DO. In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways. Molecular Immunology. 48: 2009-18. PMID 21723612 DOI: 10.1016/J.Molimm.2011.06.215 |
0.321 |
|
| 2011 |
Yoo EM, Trinh KR, Lim H, Wims LA, Morrison SL. Characterization of IgA and IgM binding and internalization by surface-expressed human Fcα/μ receptor. Molecular Immunology. 48: 1818-26. PMID 21632111 DOI: 10.1016/J.Molimm.2011.05.011 |
0.762 |
|
| 2011 |
Vega GG, Vega MI, Huerta-Yepez S, Jazirehi A, Mayani H, Martinez-Maza O, Morrison S, Bonavida B. Cytotoxic Activity of Anti-CD20-hIFN-α on Rituximab-Resistant B-NHL Clones and Synergy with Chemotherapy, Blood. 118: 3499-3499. DOI: 10.1182/Blood.V118.21.3499.3499 |
0.348 |
|
| 2011 |
Yamada RE, Steward KK, Ngarmchamnanrith G, Khare S, Sachdev R, Grewal I, Morrison S, Timmerman JM. Anti-CD20-Interferon-α Fusion Protein Demonstrates Potent Direct Growth Inhibition, Antibody-Dependent Cellular Cytotoxicity, and Enhanced Complement-Dependent Cytotoxicity Against Human B Cell Lymphomas In Vitro, and Activity Against Multiple Human NHL Xenografts In Vivo Blood. 118: 2724-2724. DOI: 10.1182/Blood.V118.21.2724.2724 |
0.437 |
|
| 2010 |
Yoo EM, Yu LJ, Wims LA, Goldberg D, Morrison SL. Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. Mabs. 2: 320-34. PMID 20431350 DOI: 10.4161/Mabs.2.3.11802 |
0.79 |
|
| 2010 |
Xuan C, Steward KK, Timmerman JM, Morrison SL. Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma. Blood. 115: 2864-71. PMID 20139095 DOI: 10.1182/Blood-2009-10-250555 |
0.659 |
|
| 2009 |
Afshar S, Olafsen T, Wu AM, Morrison SL. Characterization of an engineered human purine nucleoside phosphorylase fused to an anti-her2/neu single chain Fv for use in ADEPT. Journal of Experimental & Clinical Cancer Research : Cr. 28: 147. PMID 19958550 DOI: 10.1186/1756-9966-28-147 |
0.627 |
|
| 2009 |
Cho JS, Kim YC, Morrison SL. Inhibitors of MyD88-dependent proinflammatory cytokine production identified utilizing a novel RNA interference screening approach. Plos One. 4: e7029. PMID 19753301 DOI: 10.1371/Journal.Pone.0007029 |
0.517 |
|
| 2009 |
Afshar S, Sawaya MR, Morrison SL. Structure of a mutant human purine nucleoside phosphorylase with the prodrug, 2-fluoro-2'-deoxyadenosine and the cytotoxic drug, 2-fluoroadenine. Protein Science : a Publication of the Protein Society. 18: 1107-14. PMID 19388075 DOI: 10.1002/Pro.91 |
0.553 |
|
| 2009 |
Afshar S, Asai T, Morrison SL. Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Molecular Cancer Therapeutics. 8: 185-93. PMID 19139128 DOI: 10.1158/1535-7163.Mct-08-0652 |
0.604 |
|
| 2009 |
Mershon KL, Vasuthasawat A, Lawson GW, Morrison SL, Beenhouwer DO. Role of complement in protection against Cryptococcus gattii infection. Infection and Immunity. 77: 1061-70. PMID 19114546 DOI: 10.1128/Iai.01119-08 |
0.751 |
|
| 2009 |
Cho JS, Hsu JV, Morrison SL. Localized expression of GITR-L in the tumor microenvironment promotes CD8+ T cell dependent anti-tumor immunity. Cancer Immunology, Immunotherapy : Cii. 58: 1057-69. PMID 19018533 DOI: 10.1007/S00262-008-0622-2 |
0.556 |
|
| 2009 |
Montano RF, Penichet ML, Blackall DP, Morrison SL, Chintalacharuvu KR. Recombinant polymeric IgG anti-Rh: a novel strategy for development of direct agglutinating reagents. Journal of Immunological Methods. 340: 1-10. PMID 18848836 DOI: 10.1016/J.Jim.2008.09.011 |
0.49 |
|
| 2009 |
Mershon KL, Morrison SL. Antibody-Complement Interaction Therapeutic Monoclonal Antibodies: From Bench to Clinic. 371-383. DOI: 10.1002/9780470485408.ch16 |
0.797 |
|
| 2008 |
Cheng LS, Hwang S, Huang TH, Sheu TC, Sun R, Morrison SL, Cheng G, Shahangian A. Antibody-fused interferons as an effective approach to enhance target specificity and antiviral efficacy of type I interferons. Cell Research. 18: 1230-2. PMID 19002159 DOI: 10.1038/Cr.2008.304 |
0.616 |
|
| 2008 |
Aslam A, Quinn P, McIntosh RS, Shi J, Ghumra A, McKerrow JH, Bunting KA, Dunne DW, Doenhoff MJ, Morrison SL, Zhang K, Pleass RJ. Proteases from Schistosoma mansoni cercariae cleave IgE at solvent exposed interdomain regions. Molecular Immunology. 45: 567-74. PMID 17631966 DOI: 10.1016/J.Molimm.2007.05.021 |
0.411 |
|
| 2007 |
Morrison SL. Two heads are better than one. Nature Biotechnology. 25: 1233-4. PMID 17989683 DOI: 10.1038/Nbt1107-1233 |
0.347 |
|
| 2007 |
Huang TH, Chintalacharuvu KR, Morrison SL. Targeting IFN-alpha to B cell lymphoma by a tumor-specific antibody elicits potent antitumor activities. Journal of Immunology (Baltimore, Md. : 1950). 179: 6881-8. PMID 17982079 DOI: 10.4049/Jimmunol.179.10.6881 |
0.622 |
|
| 2007 |
Chintalacharuvu KR, Gurbaxani B, Morrison SL. Incomplete assembly of IgA2m(2) in Chinese hamster ovary cells. Molecular Immunology. 44: 3445-52. PMID 17467056 DOI: 10.1016/J.Molimm.2006.12.030 |
0.342 |
|
| 2007 |
Olafsen T, Gu Z, Sherman MA, Leyton JV, Witkosky ME, Shively JE, Raubitschek AA, Morrison SL, Wu AM, Reiter RE. Targeting, imaging, and therapy using a humanized antiprostate stem cell antigen (PSCA) antibody. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 396-405. PMID 17457214 DOI: 10.1097/Cji.0B013E318031B53B |
0.43 |
|
| 2007 |
Beenhouwer DO, Yoo EM, Lai CW, Rocha MA, Morrison SL. Human immunoglobulin G2 (IgG2) and IgG4, but not IgG1 or IgG3, protect mice against Cryptococcus neoformans infection. Infection and Immunity. 75: 1424-35. PMID 17220317 DOI: 10.1128/Iai.01161-06 |
0.798 |
|
| 2007 |
Yoo EM, Chintalacharuvu KR, Morrison SL. Recombinant IgA antibodies Mucosal Immune Defense: Immunoglobulin A. 390-415. DOI: 10.1007/978-0-387-72232-0_15 |
0.772 |
|
| 2006 |
Samuelsson M, Jendholm J, Amisten S, Morrison SL, Forsgren A, Riesbeck K. The IgD CH1 region contains the binding site for the human respiratory pathogen Moraxella catarrhalis IgD-binding protein MID. European Journal of Immunology. 36: 2525-34. PMID 16906531 DOI: 10.1002/Eji.200535594 |
0.358 |
|
| 2006 |
Ng PP, Helguera G, Daniels TR, Lomas SZ, Rodriguez JA, Schiller G, Bonavida B, Morrison SL, Penichet ML. Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. Blood. 108: 2745-54. PMID 16804109 DOI: 10.1182/Blood-2006-04-020263 |
0.701 |
|
| 2006 |
Huang TH, Morrison SL. A trimeric anti-HER2/neu ScFv and tumor necrosis factor-alpha fusion protein induces HER2/neu signaling and facilitates repair of injured epithelia. The Journal of Pharmacology and Experimental Therapeutics. 316: 983-91. PMID 16291729 DOI: 10.1124/Jpet.105.095513 |
0.599 |
|
| 2006 |
Gurbaxani BM, Morrison SL. Development of new models for the analysis of Fc-FcRn interactions. Molecular Immunology. 43: 1379-89. PMID 16183124 DOI: 10.1016/J.Molimm.2005.08.002 |
0.33 |
|
| 2006 |
Gurbaxani B, Dela Cruz LL, Chintalacharuvu K, Morrison SL. Analysis of a family of antibodies with different half-lives in mice fails to find a correlation between affinity for FcRn and serum half-life. Molecular Immunology. 43: 1462-73. PMID 16139891 DOI: 10.1016/J.Molimm.2005.07.032 |
0.422 |
|
| 2006 |
Helguera G, Dela Cruz JS, Lowe C, Ng PP, Trinh R, Morrison SL, Penichet ML. Vaccination with novel combinations of anti-HER2/neu cytokines fusion proteins and soluble protein antigen elicits a protective immune response against HER2/neu expressing tumors. Vaccine. 24: 304-16. PMID 16125282 DOI: 10.1016/J.Vaccine.2005.07.073 |
0.799 |
|
| 2006 |
Dela Cruz JS, Trinh KR, Chen HW, Ribas A, Morrison SL, Penichet ML. Anti-HER2/neu IgG3-(IL-2) and anti-HER2/neu IgG3-(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: implications in immunotherapy and vaccination strategies. Molecular Immunology. 43: 667-76. PMID 15908002 DOI: 10.1016/J.Molimm.2005.04.007 |
0.838 |
|
| 2006 |
Penichet ML, Morrison SL. Antibody Molecules, Genetic Engineering of Reviews in Cell Biology and Molecular Medicine. DOI: 10.1002/3527600906.Mcb.200200007 |
0.499 |
|
| 2005 |
Zhu L, van de Lavoir MC, Albanese J, Beenhouwer DO, Cardarelli PM, Cuison S, Deng DF, Deshpande S, Diamond JH, Green L, Halk EL, Heyer BS, Kay RM, Kerchner A, Leighton PA, ... ... Morrison SL, et al. Production of human monoclonal antibody in eggs of chimeric chickens. Nature Biotechnology. 23: 1159-69. PMID 16127450 DOI: 10.1038/Nbt1132 |
0.421 |
|
| 2005 |
Dela Cruz JS, Morrison SL, Penichet ML. Insights into the mechanism of anti-tumor immunity in mice vaccinated with the human HER2/neu extracellular domain plus anti-HER2/neu IgG3-(IL-2) or anti-HER2/neu IgG3-(GM-CSF) fusion protein. Vaccine. 23: 4793-803. PMID 15967544 DOI: 10.1016/J.Vaccine.2005.04.041 |
0.825 |
|
| 2005 |
Cho HM, Rosenblatt JD, Kang YS, Iruela-Arispe ML, Morrison SL, Penichet ML, Kwon YG, Kim TW, Webster KA, Nechustan H, Shin SU. Enhanced inhibition of murine tumor and human breast tumor xenografts using targeted delivery of an antibody-endostatin fusion protein. Molecular Cancer Therapeutics. 4: 956-67. PMID 15956253 DOI: 10.1158/1535-7163.Mct-04-0321 |
0.453 |
|
| 2005 |
Yoo EM, Morrison SL. IgA: an immune glycoprotein. Clinical Immunology (Orlando, Fla.). 116: 3-10. PMID 15925826 DOI: 10.1016/J.Clim.2005.03.010 |
0.774 |
|
| 2005 |
Asai T, Wims LA, Morrison SL. An interaction between S*tag and S*protein derived from human ribonuclease 1 allows site-specific conjugation of an enzyme to an antibody for targeted drug delivery. Journal of Immunological Methods. 299: 63-76. PMID 15914191 DOI: 10.1016/J.Jim.2005.01.020 |
0.44 |
|
| 2005 |
Asai T, Trinh R, Ng PP, Penichet ML, Wims LA, Morrison SL. A human biotin acceptor domain allows site-specific conjugation of an enzyme to an antibody-avidin fusion protein for targeted drug delivery. Biomolecular Engineering. 21: 145-55. PMID 15748688 DOI: 10.1016/J.Bioeng.2004.10.001 |
0.718 |
|
| 2004 |
Dela Cruz JS, Huang TH, Penichet ML, Morrison SL. Antibody-cytokine fusion proteins: innovative weapons in the war against cancer. Clinical and Experimental Medicine. 4: 57-64. PMID 15672942 DOI: 10.1007/S10238-004-0039-Y |
0.812 |
|
| 2004 |
Chan LA, Phillips ML, Wims LA, Trinh KR, Denham J, Morrison SL. Variable region domain exchange in human IgGs promotes antibody complex formation with accompanying structural changes and altered effector functions. Molecular Immunology. 41: 527-38. PMID 15183931 DOI: 10.1016/J.Molimm.2004.03.034 |
0.382 |
|
| 2004 |
Gala FA, Morrison SL. V region carbohydrate and antibody expression. Journal of Immunology (Baltimore, Md. : 1950). 172: 5489-94. PMID 15100290 DOI: 10.4049/Jimmunol.172.9.5489 |
0.781 |
|
| 2004 |
Trinh R, Gurbaxani B, Morrison SL, Seyfzadeh M. Optimization of codon pair use within the (GGGGS)3 linker sequence results in enhanced protein expression. Molecular Immunology. 40: 717-22. PMID 14644097 DOI: 10.1016/J.Molimm.2003.08.006 |
0.364 |
|
| 2004 |
Penichet ML, Morrison SL. Design and engineering human forms of monoclonal antibodies Drug Development Research. 61: 121-136. DOI: 10.1002/Ddr.10347 |
0.495 |
|
| 2003 |
Chintalacharuvu KR, Chuang PD, Dragoman A, Fernandez CZ, Qiu J, Plaut AG, Trinh KR, Gala FA, Morrison SL. Cleavage of the human immunoglobulin A1 (IgA1) hinge region by IgA1 proteases requires structures in the Fc region of IgA. Infection and Immunity. 71: 2563-70. PMID 12704129 DOI: 10.1128/Iai.71.5.2563-2570.2003 |
0.775 |
|
| 2003 |
Yoo EM, Wims LA, Chan LA, Morrison SL. Human IgG2 can form covalent dimers. Journal of Immunology (Baltimore, Md. : 1950). 170: 3134-8. PMID 12626570 DOI: 10.4049/Jimmunol.170.6.3134 |
0.794 |
|
| 2003 |
Dela Cruz JS, Lau SY, Ramirez EM, De Giovanni C, Forni G, Morrison SL, Penichet ML. Protein vaccination with the HER2/neu extracellular domain plus anti-HER2/neu antibody-cytokine fusion proteins induces a protective anti-HER2/neu immune response in mice. Vaccine. 21: 1317-26. PMID 12615426 DOI: 10.1016/S0264-410X(02)00741-7 |
0.812 |
|
| 2002 |
Morrison SL. Cloning, expression, and modification of antibody V regions. Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. Unit 2.12. PMID 18432877 DOI: 10.1002/0471142735.Im0212S47 |
0.425 |
|
| 2002 |
Helguera G, Morrison SL, Penichet ML. Antibody-cytokine fusion proteins: Harnessing the combined power of cytokines and antibodies for cancer therapy Clinical Immunology. 105: 233-246. PMID 12498805 DOI: 10.1006/Clim.2002.5302 |
0.484 |
|
| 2002 |
Chintalacharuvu KR, Yu LJ, Bhola N, Kobayashi K, Fernandez CZ, Morrison SL. Cysteine residues required for the attachment of the light chain in human IgA2. Journal of Immunology (Baltimore, Md. : 1950). 169: 5072-7. PMID 12391223 DOI: 10.4049/Jimmunol.169.9.5072 |
0.311 |
|
| 2002 |
Ng PP, Dela Cruz JS, Sorour DN, Stinebaugh JM, Shin SU, Shin DS, Morrison SL, Penichet ML. An anti-transferrin receptor-avidin fusion protein exhibits both strong proapoptotic activity and the ability to deliver various molecules into cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 99: 10706-11. PMID 12149472 DOI: 10.1073/Pnas.162362999 |
0.803 |
|
| 2002 |
Gala FA, Morrison SL. The role of constant region carbohydrate in the assembly and secretion of human IgD and IgA1. The Journal of Biological Chemistry. 277: 29005-11. PMID 12023968 DOI: 10.1074/Jbc.M203258200 |
0.777 |
|
| 2002 |
Yoo EM, Chintalacharuvu KR, Penichet ML, Morrison SL. Myeloma expression systems. Journal of Immunological Methods. 261: 1-20. PMID 11861062 DOI: 10.1016/S0022-1759(01)00559-2 |
0.806 |
|
| 2002 |
Morrison SL, Mohammed MS, Wims LA, Trinh R, Etches R. Sequences in antibody molecules important for receptor-mediated transport into the chicken egg yolk. Molecular Immunology. 38: 619-25. PMID 11792430 DOI: 10.1016/S0161-5890(01)00095-5 |
0.352 |
|
| 2002 |
Westin Kwon K, Lendvai N, Morrison S, Trinh KR, Casadevall A. Biological activity of a mouse-human chimeric immunoglobulin G2 antibody to Cryptococcus neoformans polysaccharide. Clinical and Diagnostic Laboratory Immunology. 9: 201-4. PMID 11777857 DOI: 10.1128/Cdli.9.1.201-204.2002 |
0.474 |
|
| 2002 |
Montaño RF, Morrison SL. Influence of the isotype of the light chain on the properties of IgG. Journal of Immunology (Baltimore, Md. : 1950). 168: 224-31. PMID 11751966 DOI: 10.4049/Jimmunol.168.1.224 |
0.362 |
|
| 2001 |
Morrison SL. Transfection of lymphoid cells Current Protocols in Immunology / Edited by John E. Coligan ... [Et Al.]. PMID 18432681 DOI: 10.1002/0471142735.Im1017Bs31 |
0.31 |
|
| 2001 |
Chintalacharuvu KR, Vuong LU, Loi LA, Larrick JW, Morrison SL. Hybrid IgA2/IgG1 antibodies with tailor-made effector functions. Clinical Immunology (Orlando, Fla.). 101: 21-31. PMID 11580223 DOI: 10.1006/Clim.2001.5083 |
0.503 |
|
| 2001 |
Peng LS, Penichet ML, Dela Cruz JS, Sampogna SL, Morrison SL. Mechanism of antitumor activity of a single-chain interleukin-12 IgG3 antibody fusion protein (mscIL-12.her2.IgG3). Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 21: 709-20. PMID 11576465 DOI: 10.1089/107999001753124444 |
0.825 |
|
| 2001 |
Penichet ML, Dela Cruz JS, Shin SU, Morrison SL. A recombinant IgG3-(IL-2) fusion protein for the treatment of human HER2/neu expressing tumors. Human Antibodies. 10: 43-9. PMID 11455061 DOI: 10.3233/Hab-2000-10107 |
0.826 |
|
| 2001 |
Zhang HF, Lu S, Morrison SL, Tomlinson S. Targeting of Functional Antibody-Decay-accelerating Factor Fusion Proteins to a Cell Surface Journal of Biological Chemistry. 276: 27290-27295. PMID 11352906 DOI: 10.1074/Jbc.M100436200 |
0.401 |
|
| 2001 |
Penichet ML, Dela Cruz JS, Challita-Eid PM, Rosenblatt JD, Morrison SL. A murine B cell lymphoma expressing human HER2 / neu undergoes spontaneous tumor regression and elicits antitumor immunity. Cancer Immunology, Immunotherapy : Cii. 49: 649-62. PMID 11258791 DOI: 10.1007/S002620000155 |
0.808 |
|
| 2001 |
Penichet ML, Morrison SL. Antibody-cytokine fusion proteins for the therapy of cancer. Journal of Immunological Methods. 248: 91-101. PMID 11223071 DOI: 10.1016/S0022-1759(00)00345-8 |
0.51 |
|
| 2000 |
Wright A, Sato Y, Okada T, Chang KH, Endo T, Morrison SL. In vivo trafficking and catabolism of IgG1 antibodies with Fc associated carbohydrates of differing structure Glycobiology. 10: 1347-1355. PMID 11159927 DOI: 10.1093/Glycob/10.12.1347 |
0.463 |
|
| 2000 |
Mateo C, Lombardero J, Moreno E, Morales A, Bombino G, Coloma J, Wims L, Morrison SL, Pérez R. Removal of amphipathic epitopes from genetically engineered antibodies: production of modified immunoglobulins with reduced immunogenicity. Hybridoma. 19: 463-71. PMID 11152398 DOI: 10.1089/027245700750053959 |
0.479 |
|
| 2000 |
Dela Cruz JS, Trinh KR, Morrison SL, Penichet ML. Recombinant anti-human HER2/neu IgG3-(GM-CSF) fusion protein retains antigen specificity and cytokine function and demonstrates antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 165: 5112-21. PMID 11046042 DOI: 10.4049/Jimmunol.165.9.5112 |
0.829 |
|
| 2000 |
Chan LA, Lyczak JB, Zhang K, Morrison SL, Saxon A. The novel human IgE epsilon heavy chain, epsilon tailpiece, is present in plasma as part of a covalent complex. Molecular Immunology. 37: 241-52. PMID 10930631 DOI: 10.1016/S0161-5890(00)00042-0 |
0.38 |
|
| 2000 |
Rifai A, Fadden K, Morrison SL, Chintalacharuvu KR. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes Journal of Experimental Medicine. 191: 2171-2181. PMID 10859341 DOI: 10.1084/Jem.191.12.2171 |
0.364 |
|
| 2000 |
Coloma MJ, Lee HJ, Kurihara A, Landaw EM, Boado RJ, Morrison SL, Pardridge WM. Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor. Pharmaceutical Research. 17: 266-74. PMID 10801214 DOI: 10.1023/A:1007592720793 |
0.339 |
|
| 1999 |
Yoo EM, Coloma MJ, Trinh KR, Nguyen TQ, Vuong LU, Morrison SL, Chintalacharuvu KR. Structural requirements for polymeric immunoglobulin assembly and association with J chain. The Journal of Biological Chemistry. 274: 33771-7. PMID 10559270 DOI: 10.1074/Jbc.274.47.33771 |
0.739 |
|
| 1999 |
Peng LS, Penichet ML, Morrison SL. A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity. Journal of Immunology (Baltimore, Md. : 1950). 163: 250-8. PMID 10384123 |
0.705 |
|
| 1999 |
Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice Laboratory Animal Science. 49: 179-188. PMID 10331548 |
0.348 |
|
| 1999 |
Chintalacharuvu KR, Morrison SL. Production and characterization of recombinant IgA Immunotechnology. 4: 165-174. PMID 10231086 DOI: 10.1016/S1380-2933(98)00012-8 |
0.447 |
|
| 1999 |
Montaño RF, Morrison SL. A colorimetric-enzymatic microassay for the quantitation of antibody- dependent complement activation Journal of Immunological Methods. 222: 73-82. PMID 10022374 DOI: 10.1016/S0022-1759(98)00181-1 |
0.377 |
|
| 1999 |
Zhang HF, Yu J, Bajwa E, Morrison SL, Tomlinson S. Targeting of functional antibody-CD59 fusion proteins to a cell surface Journal of Clinical Investigation. 103: 55-61. PMID 9884334 DOI: 10.1172/Jci4607 |
0.378 |
|
| 1998 |
Mohammed SM, Morrison S, Wims L, Trinh KR, Wildeman AG, Bonselaar J, Etches RJ. Deposition of genetically engineered human antibodies into the egg yolk of hens. Immunotechnology : An International Journal of Immunological Engineering. 4: 115-25. PMID 9853953 DOI: 10.1016/S1380-2933(98)00013-X |
0.329 |
|
| 1998 |
Challita-Eid PM, Abboud CN, Morrison SL, Penichet ML, Rosell KE, Poles T, Hilchey SP, Planelles V, Rosenblatt JD. A RANTES-antibody fusion protein retains antigen specificity and chemokine function Journal of Immunology. 161: 3729-3736. PMID 9759898 |
0.35 |
|
| 1998 |
Zuckier LS, Chang CJ, Scharff MD, Morrison SL. Chimeric human-mouse IgG antibodies with shuffled constant region exons demonstrate that multiple domains contribute to in vivo half-life. Cancer Research. 58: 3905-8. PMID 9731501 |
0.35 |
|
| 1998 |
Penichet ML, Harvill ET, Morrison SL. An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity Journal of Interferon and Cytokine Research. 18: 597-607. PMID 9726441 DOI: 10.1089/Jir.1998.18.597 |
0.656 |
|
| 1998 |
Challita-Eid PM, Penichet ML, Shin SU, Poles T, Mosammaparast N, Mahmood K, Slamon DJ, Morrison SL, Rosenblatt JD. A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway Journal of Immunology. 160: 3419-3426. PMID 9531302 |
0.31 |
|
| 1998 |
Wright A, Morrison SL. Effect of C2-associated carbohydrate structure on Ig effector function: Studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells Journal of Immunology. 160: 3393-3402. PMID 9531299 |
0.4 |
|
| 1997 |
Sensel MG, Kane LM, Morrison SL. Amino acid differences in the n-terminus of C(h)2 influence the relative abilities of IgG2 and IgG3 to activate complement Molecular Immunology. 34: 1019-1029. PMID 9488053 DOI: 10.1016/S0161-5890(97)00112-0 |
0.386 |
|
| 1997 |
Penichet ML, Harvill ET, Morrison SL. Antibody-IL-2 fusion proteins: A novel strategy for immune potentiation Human Antibodies. 8: 106-118. PMID 9322080 DOI: 10.3233/Hab-1997-8301 |
0.715 |
|
| 1997 |
Chintalacharuvu KR, Morrison SL. Production of secretory immunoglobulin A by a single mammalian cell Proceedings of the National Academy of Sciences of the United States of America. 94: 6364-6368. PMID 9177223 DOI: 10.1073/Pnas.94.12.6364 |
0.334 |
|
| 1997 |
Coloma MJ, Morrison SL. Design and production of novel tetravalent bispecific antibodies Nature Biotechnology. 15: 159-163. PMID 9035142 DOI: 10.1038/Nbt0297-159 |
0.485 |
|
| 1997 |
Wright A, Morrison SL. Effect of glycosylation on antibody function: Implications for genetic engineering Trends in Biotechnology. 15: 26-32. PMID 9032990 DOI: 10.1016/S0167-7799(96)10062-7 |
0.486 |
|
| 1997 |
Sensel MG, Josefina Coloma M, Harvill ET, Shin SU, Smith RIF, Morrison SL. Engineering novel antibody molecules Chemical Immunology. 65: 129-158. PMID 9018876 DOI: 10.1159/000425636 |
0.629 |
|
| 1997 |
McGrath JP, Cao X, Schutz A, Lynch P, Ebendal T, Coloma MJ, Morrison SL, Putney SD. Bifunctional fusion between nerve growth factor and a transferrin receptor antibody. Journal of Neuroscience Research. 47: 123-33. PMID 9008143 DOI: 10.1002/(Sici)1097-4547(19970115)47:2<123::Aid-Jnr1>3.0.Co;2-H |
0.439 |
|
| 1997 |
Challita PM, Abboud CN, Rosell KE, Penichet M, Morrison SL, Rossenblatt JD. CHARACTERIZATION OF A RANTES-ANTIBODY FUSION PROTEIN FOR CANCER IMMUNOTHERAPY Journal of Immunotherapy. 20: 416. DOI: 10.1097/00002371-199709000-00076 |
0.413 |
|
| 1996 |
LaVallee TM, Morrison SL. Identification and functional characterization of a highly conserved sequence in the intron of the kappa light chain gene. Molecular Immunology. 33: 973-88. PMID 8960122 DOI: 10.1016/S0161-5890(96)00036-3 |
0.328 |
|
| 1996 |
Harvill ET, Fleming JM, Morrison SL. In Vivo Properties of an IgG3-IL-2 Fusion Protein: A General Strategy for Immune Potentiation 1 Journal of Immunology. 157: 3165-3170. PMID 8816429 |
0.586 |
|
| 1996 |
Lyczak JB, Zhang K, Saxon A, Morrison SL. Expression of novel secreted isoforms of human immunoglobulin E proteins Journal of Biological Chemistry. 271: 3428-3436. PMID 8631944 DOI: 10.1074/Jbc.271.7.3428 |
0.42 |
|
| 1996 |
Morrison S, Coloma M, Harvill E. Genetically engineered antibodies with improved functional properties Immunotechnology. 2: 69-70. DOI: 10.1016/1380-2933(96)80678-6 |
0.607 |
|
| 1995 |
Harvill ET, Morrison SL. An IgG3-IL2 fusion protein activates complement, binds FcγRI, generates LAK activity and shows enhanced binding to the high affinity IL-2R Immunotechnology. 1: 95-105. PMID 9373338 DOI: 10.1016/1380-2933(95)00009-7 |
0.641 |
|
| 1995 |
Smith RIF, Coloma MJ, Morrison SL. Addition of a μ-tailpiece to IgG results in polymeric antibodies with enhanced effector functions including complement-mediated cytolysis by IgG4 Journal of Immunology. 154: 2226-2236. PMID 7868896 |
0.388 |
|
| 1995 |
Poon PH, Morrison SL, Schumaker VN. Structure and function of several anti-dansyl chimeric antibodies formed by domain interchanges between human IgM and mouse IgG2b. The Journal of Biological Chemistry. 270: 8571-7. PMID 7721758 DOI: 10.1074/Jbc.270.15.8571 |
0.412 |
|
| 1995 |
Shin SU, Friden P, Moran M, Olson T, Kang YS, Pardridge WM, Morrison SL. Transferrin-antibody fusion proteins are effective in brain targeting. Proceedings of the National Academy of Sciences of the United States of America. 92: 2820-4. PMID 7708731 DOI: 10.1073/Pnas.92.7.2820 |
0.375 |
|
| 1995 |
Raghavan M, Bonagura VR, Morrison SL, Bjorkman PJ. Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. Biochemistry. 34: 14649-57. PMID 7578107 DOI: 10.1021/Bi00045A005 |
0.317 |
|
| 1995 |
Endo T, Wright A, Morrison SL, Kobata A. Glycosylation of the variable region of immunoglobulin G-site specific maturation of the sugar chains Molecular Immunology. 32: 931-940. PMID 7476998 DOI: 10.1016/0161-5890(95)00078-S |
0.419 |
|
| 1995 |
Morrison SL, Shin SU. Genetically engineered antibodies and their application to brain delivery Advanced Drug Delivery Reviews. 15: 147-175. DOI: 10.1016/0169-409X(95)00008-U |
0.49 |
|
| 1995 |
Chintalacharuvu KR, Morrison SL. Chimeric antibodies: Production and applications Methods: a Companion to Methods in Enzymology. 8: 73-82. DOI: 10.1006/Meth.1995.9999 |
0.504 |
|
| 1994 |
Zuckier LS, Georgescu L, Chang CJ, Scharff MD, Morrison SL. The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin G. Cancer. 73: 794-9. PMID 8306262 DOI: 10.1002/1097-0142(19940201)73:3+<794::Aid-Cncr2820731308>3.0.Co;2-A |
0.411 |
|
| 1994 |
Wright A, Morrison SL. Effect of altered CH2-associated carbohydrate structure on the functional properties and in vivo fate of chimeric mouse-human immunoglobulin G1 Journal of Experimental Medicine. 180: 1087-1096. PMID 8064227 DOI: 10.1084/Jem.180.3.1087 |
0.482 |
|
| 1994 |
Phillips ML, Tao MH, Morrison SL, Schumaker VN. Human/mouse chimeric monoclonal antibodies with human IgG1, IgG2, IgG3 and IgG4 constant domains: electron microscopic and hydrodynamic characterization. Molecular Immunology. 31: 1201-10. PMID 7935507 DOI: 10.1016/0161-5890(94)90034-5 |
0.454 |
|
| 1994 |
Smith RIF, Morrison SL. Recombinant polymerie IgG: An approach to engineering more potent antibodies Bio/Technology. 12: 683-688. PMID 7764912 DOI: 10.1038/Nbt0794-683 |
0.465 |
|
| 1994 |
He X, Archer GE, Wikstrand CJ, Morrison SL, Zalutsky MR, Bigner DD, Batra SK. Generation and characterization of a mouse/human chimeric antibody directed against extracellular matrix protein tenascin Journal of Neuroimmunology. 52: 127-137. PMID 7518471 DOI: 10.1016/0165-5728(94)90106-6 |
0.486 |
|
| 1993 |
Chou CL, Morrison SL. An insertion-deletion event in murine immunoglobulin kappa gene resembles mutations at heavy-chain disease loci Somatic Cell and Molecular Genetics. 19: 131-139. PMID 8511672 DOI: 10.1007/Bf01233529 |
0.317 |
|
| 1993 |
Shin SU, Wright A, Morrison SL. Hybrid antibodies International Reviews of Immunology. 10: 177-186. PMID 8360584 DOI: 10.3109/08830189309061694 |
0.343 |
|
| 1993 |
Tao MH, Smith RIF, Morrison SL. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation Journal of Experimental Medicine. 178: 661-667. PMID 8340761 DOI: 10.1084/Jem.178.2.661 |
0.424 |
|
| 1993 |
Hamilton RG, Morrison SL. Epitope mapping of human immunoglobulin-specific murine monoclonal antibodies with domain-switched, deleted and point-mutated chimeric antibodies Journal of Immunological Methods. 158: 107-122. PMID 7679128 DOI: 10.1016/0022-1759(93)90263-7 |
0.481 |
|
| 1993 |
Wright A, Morrison SL. Antibody variable region glycosylation: biochemical and clinical effects Springer Seminars in Immunopathology. 15: 259-273. PMID 7504841 DOI: 10.1007/Bf00201106 |
0.461 |
|
| 1992 |
Morrison SL. In vitro antibodies: Strategies for production and application Annual Review of Immunology. 10: 239-265. PMID 1590987 DOI: 10.1146/Annurev.Iy.10.040192.001323 |
0.406 |
|
| 1992 |
Bonagura VR, Artandi SE, Agostino N, Tao MH, Morrison SL. Mapping rheumatoid factor binding sites using genetically engineered, chimeric IgG antibodies. Dna and Cell Biology. 11: 245-52. PMID 1567557 DOI: 10.1089/Dna.1992.11.245 |
0.407 |
|
| 1992 |
Wright A, Shin SU, Morrison SL. Genetically engineered antibodies: Progress and prospects Critical Reviews in Immunology. 12: 125-168. PMID 1476621 |
0.397 |
|
| 1992 |
Braun J, Saxon A, Wall R, Morrison SL. The second century of the antibody - Molecular perspectives in regulation, pathophysiology, and therapeutic applications Western Journal of Medicine. 157: 158-168. PMID 1441467 |
0.364 |
|
| 1992 |
Shin SU, Wright A, Bonagura V, Morrison SL. Genetically-engineered antibodies : Tools for the study of diverse properties of the antibody molecule Immunological Reviews. 86-107. PMID 1286874 DOI: 10.1111/J.1600-065X.1992.Tb01522.X |
0.411 |
|
| 1991 |
Wright A, Tao MH, Kabat EA, Morrison SL. Antibody variable region glycosylation: position effects on antigen binding and carbohydrate structure. The Embo Journal. 10: 2717-23. PMID 1717254 DOI: 10.1002/J.1460-2075.1991.Tb07819.X |
0.449 |
|
| 1990 |
Tan LK, Shopes RJ, Oi VT, Morrison SL. Influence of the hinge region on complement activation, C1q binding, and segmental flexibility in chimeric human immunoglobulins Proceedings of the National Academy of Sciences of the United States of America. 87: 162-166. PMID 2296577 DOI: 10.1073/Pnas.87.1.162 |
0.413 |
|
| 1990 |
Morrison SL, Schlom J. Recombinant chimeric monoclonal antibodies Important Advances in Oncology. 3-18. PMID 2182522 |
0.359 |
|
| 1990 |
Shin SU, Morrison SL. Expression and characterization of an antibody binding specificity joined to insulin-like growth factor 1: Potential applications for cellular targeting Proceedings of the National Academy of Sciences of the United States of America. 87: 5322-5326. PMID 2115168 DOI: 10.1073/Pnas.87.14.5322 |
0.426 |
|
| 1990 |
Black A, Kabat EA, Morrison SL. Rabbit antisera to the variable region domains of an anti-alpha(1----6) dextran using E. coli-produced VL and VH fusion proteins as immunogens. Journal of Immunological Methods. 127: 123-30. PMID 1690781 DOI: 10.1016/0022-1759(90)90348-Y |
0.35 |
|
| 1989 |
Morrison SL, Ol VT. Genetically engineered antibody molecules Advances in Immunology. 44: 65-92. PMID 2646862 DOI: 10.1016/S0065-2776(08)60640-9 |
0.431 |
|
| 1989 |
Morrison SL. Genetically engineered (Chimeric) antibodies Hospital Practice. 24: 65-80. PMID 2551912 DOI: 10.1080/21548331.1989.11703799 |
0.455 |
|
| 1989 |
Shin SU, Morrison SL. Production and properties of chimeric antibody molecules Methods in Enzymology. 178: 459-476. PMID 2513467 DOI: 10.1016/0076-6879(89)78034-4 |
0.385 |
|
| 1989 |
Tao MH, Morrison SL. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region Journal of Immunology. 143: 2595-2601. PMID 2507634 |
0.345 |
|
| 1989 |
Wallick SC, Kabat EA, Morrison SL. The effect of isotype and the J kappa region on antigen binding and idiotype expression by antibodies binding alpha (1----6) dextran. Journal of Immunology (Baltimore, Md. : 1950). 142: 1235-44. PMID 2464641 |
0.3 |
|
| 1988 |
Wallick SC, Kabat EA, Morrison SL. Glycosylation of a VH residue of a monoclonal antibody against alpha (1----6) dextran increases its affinity for antigen. The Journal of Experimental Medicine. 168: 1099-109. PMID 2459288 DOI: 10.1084/Jem.168.3.1099 |
0.366 |
|
| 1988 |
Morrison SL, Canfield S, Porter S, Tan LK, Tao MH, Wims LA. Production and characterization of genetically engineered antibody molecules. Clinical Chemistry. 34: 1668-1675. DOI: 10.1093/clinchem/34.9.1668 |
0.345 |
|
| 1988 |
Tan LK, Morrison SL. Antibody structure and antibody engineering Advanced Drug Delivery Reviews. 2: 129-142. DOI: 10.1016/0169-409X(88)90030-0 |
0.313 |
|
| 1987 |
Morrison SL, Wims L, Wallick S, Tan L, Oi VT. Genetically engineered antibody molecules and their application Annals of the New York Academy of Sciences. 507: 187-198. PMID 3327412 |
0.35 |
|
| 1987 |
Sun LK, Curtis P, Rakowicz-Szulczynska E, Ghrayeb J, Chang N, Morrison SL, Koprowski H. Chimeric antibody with human constant regions and mouse variable regions directed against carcinoma-associated antigen 17-1A. Proceedings of the National Academy of Sciences of the United States of America. 84: 214-8. PMID 3025856 DOI: 10.1073/Pnas.84.1.214 |
0.406 |
|
| 1984 |
Morrison SL, Johnson MJ, Herzenberg LA, Oi VT. Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains Proceedings of the National Academy of Sciences of the United States of America. 81: 6851-6855. PMID 6436822 |
0.38 |
|
| 1983 |
Oi VT, Morrison SL, Herzenberg LA, Berg P. Immunoglobulin gene expression in transformed lymphoid cells Proceedings of the National Academy of Sciences of the United States of America. 80: 825-829. PMID 6402777 DOI: 10.1073/Pnas.80.3.825 |
0.353 |
|
| 1982 |
Berger CL, Morrison S, Chu A, Patterson J, Estabrook A, Takezaki S, Sharon J, Warburton D, Irigoyen O, Edelson RL. Diagnosis of cutaneous T cell lymphoma by use of monoclonal antibodies reactive with tumor-associated antigens. The Journal of Clinical Investigation. 70: 1205-15. PMID 6217214 DOI: 10.1172/Jci110719 |
0.384 |
|
| 1982 |
Sharon J, D'Hoostelaere L, Potter M, Kabat EA, Morrison SL. A cross-reactive idiotype, QUPC52 IdX, present on most but not all anti-alpha (1 replaced by 6) dextran-specific IgM and IgA hybridoma antibodies with combining sites of different sizes. Journal of Immunology (Baltimore, Md. : 1950). 128: 498-500. PMID 6172490 |
0.365 |
|
| 1981 |
Matsuuchi L, Sharon J, Morrison SL. An analysis of heavy chain glycopeptides of hybridoma antibodies: Correlation between antibody specificity and sialic acid content Journal of Immunology. 127: 2188-2190. PMID 6795268 |
0.344 |
|
| 1981 |
Vora S, Wims LA, Durham S, Morrison SL. Production and characterization of monoclonal antibodies to the subunits of human phosphofructokinase: New tools for the immunochemical and genetic analyses of isozymes Blood. 58: 823-829. PMID 6456026 |
0.308 |
|
| 1981 |
Dackowski W, Morrison SL. Two alpha heavy chain disease proteins with different genomic deletions demonstrate that nonexpressed alpha heavy chain genes contain methylated bases Proceedings of the National Academy of Sciences of the United States of America. 78: 7091-7095. PMID 6273910 DOI: 10.1073/Pnas.78.11.7091 |
0.315 |
|
| 1981 |
Monk RJ, Morrison SL, Milcarek C. Heavy-chain mutants derived from γ2b mouse myeloma: Characterization of heavy-chain messenger ribonucleic acid, proteins, and secretion in deletion mutants and messenger ribonucleic acid in γ2a mutant progeny Biochemistry. 20: 2330-2339. PMID 6263311 DOI: 10.1021/Bi00511A040 |
0.34 |
|
| 1981 |
Sharon J, Kabat EA, Morrison SL. Studies on mouse hybridomas secreting IgM or IgA antibodies to alpha(1 to 6)-linked dextran. Molecular Immunology. 18: 831-46. PMID 6175897 DOI: 10.1016/0161-5890(81)90005-5 |
0.305 |
|
| 1981 |
Matsuuchi L, Wims LA, Morrison SL. A variant of the dextran-binding mouse plasmacytoma J558 with altered glycosylation of its heavy chain and decreased reactivity with polymeric dextran Biochemistry. 20: 4827-4835. PMID 6170317 DOI: 10.1021/Bi00520A004 |
0.384 |
|
| 1979 |
Sharon J, Morrison SL, Kabat EA. Detection of specific hybridoma clones by replica immunoadsorption of their secreted antibodies Proceedings of the National Academy of Sciences of the United States of America. 76: 1420-1424. PMID 286325 DOI: 10.1073/Pnas.76.3.1420 |
0.433 |
|
| 1972 |
Terres G, Morrison SL, Habicht GS, Stoner RD. Appearance of an early "primed state" in mice following the concomitant injections of antigen and specific antiserum Journal of Immunology. 108: 1473-1481. PMID 5031322 |
0.71 |
|
| 1972 |
Morrison SL, Koshland ME. Characterization of the J chain from polymeric immunoglobulins (IgA-IgM-immunological specificity-primary structure) Proceedings of the National Academy of Sciences of the United States of America. 69: 124-128. PMID 4109595 DOI: 10.1073/Pnas.69.1.124 |
0.335 |
|
| 1968 |
Terres G, Morrison SL, Habicht GS. A Quantitative Difference in the Immune Response between Male and Female Mice Proceedings of the Society For Experimental Biology and Medicine. 127: 664-667. PMID 5651115 DOI: 10.3181/00379727-127-32768 |
0.707 |
|
| 1967 |
Terres G, Morrison SL. Enhanced immunologic sensitization of mice by the simultaneous injection of antigen and specific antiserum. 3. The role of antigen in controlling the immune response elicited with immune complexes Journal of Immunology. 98: 584-592. PMID 4164059 |
0.729 |
|
| 1966 |
Morrison SL, Terres G. Enhanced immunologic sensitization of mice by the simultaneous injection of antigen and specific antiserum. II. Effect of varying the antigen-antibody ratio and the amount of immune complex injected Journal of Immunology. 96: 901-905. PMID 5913760 |
0.745 |
|
| 1965 |
MORRISON SL, TERRES G. IMMUNE DEGRADATION IN PASSIVELY SENSITIZED MICE. II. DEGRADATION OF Journal of Immunology (Baltimore, Md. : 1950). 94: 667-673. PMID 14296285 |
0.694 |
|
| Show low-probability matches. |